Special NoticePosted Apr 15, 2026·Original deadline passed (Apr 17). See latest amendment for current deadline.

Notice of Intent to Sole Source - Rapid fFN

Defense Health Agency · DEFENSE HEALTH AGENCY

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
325413
Value
Not stated
Solicitation
HT9406
Set-aside
No Set aside used
PSC
6550
Place
Camp Lejeune, NC, USA
Contact
Koffi Alognon (koffi.e.alognon.civ@health.mil)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT9406 in this department, oldest first.

Early notice
  • Apr 15, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Expected award: Any day (median passed). Typical range Feb 10, 2026 to Mar 30, 2026; middle Feb 21, 2026.
Measured from 67 past early notices at Defense Health Agency (Dha) that later posted an award (middle half of cases, counted from Jan 21, 2026).
Responses are due Apr 17, 2026, so an award before then is unlikely; past cases include short solicitations.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-SE) intends to negotiate on a sole source basis IAW FAR 12.102, For acquisitions valued at or below the simplified acquisition threshold (SAT), document the decision that only one source is available and the basis for the decision. The proposed source is Hologic Sales and Services, LLC of 250 Campus Drive, Marlborough MA 01752-3020. The Naval Medical Center Camp Lejeune (NMCCL), NC Laboratory Department has a requirement for TLiIQ System to include one tabletop analyzer and all necessary reag… (show all)

ents, consumables, and other necessary supplies. This requirement is to provide continuation of fetal fibronectin testing within the Laboratory at NMCCL. Fetal fibronectin testing is deemed necessary by physicians to successfully care for pregnant patients as this test is used to determine pre-term labor. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 325413. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, vendors interested in responding to this notice will need to submit sufficient technical data to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email technical capability statement (formats for submission: PDF or MS Word) to Koffi Alognon at koffi.e.alognon.civ@health.mil . Closing date for challenges is no later than 08:00 AM ET on 17 April 2026. No phone calls will

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same product/service code (PSC) 6550 and NAICS 325413.

Single-winner award sizes (3): middle half $554K to $2.7M, median $837K; range $271K to $4.5M.

WinnerAwardsValueLast
ABBOTT LABORATORIES INC. · $ABT · $45.1B1$4.5MMar 10, 2026
QUIDELORTHO SALES COMPANY · $QDEL · $2.7B1$837KMay 27, 2026
WERFEN USA LLC1$271KJan 5, 2026

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Investor context
  • $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 3 past awards, $837K, is under 0.1% of that. SEC filing
  • $QDEL reported $2.7B revenue (12 months to Jun 28, 2026). The median single-winner award in these 3 past awards, $837K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (4 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • $46K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 2 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.